Home | Articles
Published on:March 2021
Indian Journal of Pharmaceutical Education and Research, 2021; 55(1s):s312-s317
Original Article | doi:10.5530/ijper.55.1s.64

Investigation of the Effects of Polypharmacy on Cognitive Functions: Cohort Study


Authors and affiliation (s):

Muhammed Yunus Bektay1,*, Mustafa Gokce2, Rabia Selvitop3, Erkut Bolat4, Gulsen Babacan Yildiz3

1Faculty of Pharmacy, Department of Clinical Pharmacy, Bezmialem Vakıf University, Adnan Menderes Bulvarı (Vatan Street) Fatih / Istanbul, TURKEY.

2Faculty of Pharmacy, Department of Pharmacology, Bezmialem Vakıf University, Adnan Menderes Bulvarı (Vatan Street) Fatih / Istanbul, TURKEY.

3Faculty of Medicine, Department of Neurology, Bezmialem Vakıf University, Adnan Menderes Bulvarı (Vatan Street) Fatih / Istanbul, TURKEY.

4Department of Biostatistics and Medical Informatics, Faculty of Medicine, Istanbul University, Istanbul, TURKEY.

Abstract:

Background: Alzheimer’s Disease (AD) is a major concern in growing chronic diseases in the geriatric society and its connection with polypharmacy has not been sufficiently understood. Aim: This Study investigate the association between Alzheimer’s disease and polypharmacy. Methods: A prospective cohort study. Patients with diagnosis of the AD and being older than 55 included in study between March 2017 and September 2017 who applied at the Bezmialem Vakif University Hospital, Istanbul. According to number of used medicine participant divided 3 groups. Age, sex, weight, height were recorded as Socio-demographic variables, a physical and cognitive examination was also performed to determine Mini-Mental State Exam (MMSE) and Katz-Activities of Daily Living (KATZADL) scores. Deterioration of cognitive functions has been associated with alteration of MMSE between 6 months among the groups. Results: We included 79 AD patients and >55 years old into study. Reduction of MMSE scores between six month period were, 1.0 point decrease (p=0.034), 1.29 points decrease (p=0.003) and 2.05 points decrease (p=0.001) respectively. There is statistically significant difference between group I to III, KATZ- ADL (p=0.07). Conclusion: In our study the largest decline in cognitive function seen in group with the highest number of medicine used. Cognitive functions has declined in three groups after 6 months but this cannot be directly linked with polypharmacy. Cognitive and functional status has affected from multiple drug use. There is a need for more detailed and bigger clinical studies about the relationship between polypharmacy and AD.'

Key words: Alzheimer’s disease, Dementia, Polypharmacy, Elderly, KATZ-ADL, MMSE.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).

 

Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs